NeueHealth Inc NEUE.N, NEUE.K is expected to show a fall in quarterly revenue when it reports results on March 20 for the period ending December 31 2024
The Doral Florida-based company is expected to report a 14.0% decrease in revenue to $251.93 million from $292.87 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.
LSEG's mean analyst estimate for NeueHealth Inc is for a loss of $3.99 per share.
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 2 "hold" and 1 "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for NeueHealth Inc is $7.00, above its last closing price of $4.66.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Sep. 30 2024 | -2.73 | -3.10 | -3.92 | Missed | -26.5 |
Jun. 30 2024 | -3.26 | -3.26 | -7.27 | Missed | -123 |
Mar. 31 2024 | -5.30 | -5.30 | -7.54 | Missed | -42.3 |
Dec. 31 2023 | -4.16 | -4.16 | 20.05 | Beat | 582 |
Sep. 30 2023 | -4.52 | -4.36 | -8.53 | Missed | -95.6 |
Jun. 30 2023 | -5.34 | -5.45 | -3.98 | Beat | 26.9 |
Mar. 31 2023 | -7.47 | -7.60 | -14.40 | Missed | -89.5 |
Dec. 31 2022 | -41.72 | -40.80 | -27.20 | Beat | 33.3 |
This summary was machine generated March 18 at 12:48 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。